Watch Ticker

SCYNEXIS, Inc.

Go to SCYNEXIS, Inc. Website

$0.73

0.02 (2.95%)

Live

Previous Close

$0.709

Day Range

$0.6904 - $0.76

Previous Day Range

$0.6802 - $0.7125

Market Cap

$27.2 million USD

Day Vol.

209811

Previous Day Vol.

127336

Currency

USD

Primary Exchange

Nasdaq

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight

A leading company engaged DelveInsight to conduct a comprehensive study on the myopia market, including prevalence, treatment patterns, and market forecasts across the APAC region. DelveInsight's analysis provided strategic insights to help the client optimize its market entry and differentiation strategies.

Related tickers: SCYX, EYEN.

Read Full Article

Scynexis, Inc. - SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024

SCYNEXIS, a biotechnology company, announced upcoming presentations of preclinical data on its second-generation antifungal compound SCY-247 at IDWeek 2024. SCY-247 is in pre-IND development and has shown broad-spectrum antifungal activity, including against multidrug-resistant pathogens.

Related tickers: SCYX.

Read Full Article

Trending Tickers

Please sign in to view